COSMOS Pharmaceutical (3349) Stock Overview
Engages in the retail sale of pharmaceuticals, cosmetics, daily necessities, general food products in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 3349 from our risk checks.
3349 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
COSMOS Pharmaceutical Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥9,053.00 |
| 52 Week High | JP¥10,045.00 |
| 52 Week Low | JP¥6,347.00 |
| Beta | 0.23 |
| 1 Month Change | -4.64% |
| 3 Month Change | 1.15% |
| 1 Year Change | 24.01% |
| 3 Year Change | 29.61% |
| 5 Year Change | 1.95% |
| Change since IPO | 2,785.42% |
Recent News & Updates
Here's Why We Think COSMOS Pharmaceutical (TSE:3349) Is Well Worth Watching
Aug 15
Here's What Analysts Are Forecasting For COSMOS Pharmaceutical Corporation (TSE:3349) After Its Annual Results
Jul 16Recent updates
Here's Why We Think COSMOS Pharmaceutical (TSE:3349) Is Well Worth Watching
Aug 15Here's What Analysts Are Forecasting For COSMOS Pharmaceutical Corporation (TSE:3349) After Its Annual Results
Jul 16Return Trends At COSMOS Pharmaceutical (TSE:3349) Aren't Appealing
Jul 04Is COSMOS Pharmaceutical (TSE:3349) A Risky Investment?
Jun 02Investor Optimism Abounds COSMOS Pharmaceutical Corporation (TSE:3349) But Growth Is Lacking
May 17COSMOS Pharmaceutical Corporation Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Apr 16Should You Be Adding COSMOS Pharmaceutical (TSE:3349) To Your Watchlist Today?
Mar 27COSMOS Pharmaceutical's (TSE:3349) Returns On Capital Not Reflecting Well On The Business
Mar 11COSMOS Pharmaceutical Corporation's (TSE:3349) Business Is Yet to Catch Up With Its Share Price
Jan 31COSMOS Pharmaceutical Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Jan 17Here's Why COSMOS Pharmaceutical (TSE:3349) Can Manage Its Debt Responsibly
Dec 25COSMOS Pharmaceutical's (TSE:3349) Returns On Capital Not Reflecting Well On The Business
Nov 18We Think COSMOS Pharmaceutical (TSE:3349) Can Stay On Top Of Its Debt
Sep 26Shareholder Returns
| 3349 | JP Consumer Retailing | JP Market | |
|---|---|---|---|
| 7D | 3.1% | 1.2% | 1.7% |
| 1Y | 24.0% | 14.4% | 22.1% |
Return vs Industry: 3349 exceeded the JP Consumer Retailing industry which returned 14.4% over the past year.
Return vs Market: 3349 exceeded the JP Market which returned 22.1% over the past year.
Price Volatility
| 3349 volatility | |
|---|---|
| 3349 Average Weekly Movement | 3.8% |
| Consumer Retailing Industry Average Movement | 2.8% |
| Market Average Movement | 3.3% |
| 10% most volatile stocks in JP Market | 7.6% |
| 10% least volatile stocks in JP Market | 1.7% |
Stable Share Price: 3349 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 3349's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 5,709 | Hideaki Yokoyama | www.cosmospc.co.jp |
COSMOS Pharmaceutical Corporation engages in the retail sale of pharmaceuticals, cosmetics, daily necessities, general food products in Japan. The company offers general medicines, energy drinks, oral care products, nursing care products, vitamins, health foods, diet foods, and prescriptions; and cosmetics, hair care products, and bath products. It also provides baby products, detergents, insect repellents, air fresheners, bath and toilet products, cooking supplies, gardening supplies, car supplies, and clothing; processed foods, daily necessities, seasonings, confectionery, beverages, and alcohol; and tobacco and other products.
COSMOS Pharmaceutical Corporation Fundamentals Summary
| 3349 fundamental statistics | |
|---|---|
| Market cap | JP¥717.52b |
| Earnings (TTM) | JP¥30.98b |
| Revenue (TTM) | JP¥1.01t |
Is 3349 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3349 income statement (TTM) | |
|---|---|
| Revenue | JP¥1.01t |
| Cost of Revenue | JP¥798.11b |
| Gross Profit | JP¥213.28b |
| Other Expenses | JP¥182.30b |
| Earnings | JP¥30.98b |
Last Reported Earnings
May 31, 2025
Next Earnings Date
Oct 14, 2025
| Earnings per share (EPS) | 390.85 |
| Gross Margin | 21.09% |
| Net Profit Margin | 3.06% |
| Debt/Equity Ratio | 16.7% |
How did 3349 perform over the long term?
See historical performance and comparisonDividends
Does 3349 pay a reliable dividends?
See 3349 dividend history and benchmarks| COSMOS Pharmaceutical dividend dates | |
|---|---|
| Ex Dividend Date | Nov 27 2025 |
| Dividend Pay Date | Feb 12 2026 |
| Days until Ex dividend | 74 days |
| Days until Dividend pay date | 151 days |
Does 3349 pay a reliable dividends?
See 3349 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/09/13 20:14 |
| End of Day Share Price | 2025/09/12 00:00 |
| Earnings | 2025/05/31 |
| Annual Earnings | 2025/05/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
COSMOS Pharmaceutical Corporation is covered by 17 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Arashi Nishizawa | BofA Global Research |
| Mitsuru Takayanagi | Citigroup Inc |
| Jun Kawahara | Daiwa Securities Co. Ltd. |